Defining the at risk patients for contrast induced nephropathy after coronary angiography; 24-h urine creatinine versus Cockcroft-Gault equation or serum creatinine level

Journal of Research in Medical Sciences

Volumn 17, Issue 9, 2012, Pages 859-864

  Assareh, Ahmadreza ^a   Yazdankhah, Saeed ^a   Ahmadzadeh, Ahmad ^a   Yadollahzadeh, Mahdi ^b   Nasehi, Nasim ^a   Haybar, Habib ^a  

^a AHVAZ JUNDISHAPUR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

24 hour urine creatinine; Cockcroft gault equation; Contrast induced nephropathy; Coronary angiography; Glomerular filtration rate; Serum creatinine

Indexed keywords

CONTRAST MEDIUM; CREATININE; IODIXANOL; METFORMIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; COCKCROFT GAULT EQUATION; CONTRAST INDUCED NEPHROPATHY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DIABETES MELLITUS; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL PARAMETERS; PREDICTIVE VALUE; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SENSITIVITY AND SPECIFICITY;

EID: 84869413347     PISSN: 17351995     EISSN: 17357136     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease: Current concepts and dilemmas. J Am Coll Cardiol 2004;44:1343-53.
2. Murphy SW, Barrett BJ, Parfrey PS. Contrast nephropathy. J Am Soc Nephrol 2000;11:177-82.
3. Schweiger MJ, Chambers CE, Davidson CJ, Blankenship J, Bhalla NP, Block PC, et al. Prevention of contrast induced nephropathy: Recommendations for the high risk patient undergoing cardiovascular procedures. Catheter Cardiovasc Interv 2007;69:135-40.
4. Porter GA. Contrast-associated nephropathy. Am J Cardiol 1989;64:22E-6E.
5. Boccalandro F, Amhad M, Smalling RW, Sdringola S. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv 2003;58:336-41.
6. Gleeson TG, Bulugahapitiya S. Contrast-induced nephropathy. AJR Am J Roentgenol 2004;183:1673-89.
7. Shyu KG, Cheng JJ, Kuan P. cetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure. J Am Coll Cardiol 2002;40:1383-8.
8. Kim U, Kim YJ, Lee WJ, Lee SH, Hong GR, Park JS, et al. The estimated glomerular filtration rate with using the mayo clinic quadratic equation as a new predictor for developing contrast induced nephropathy in patients with angina pectoris. Korean Circ J 2008;38:301-4.
9. Verhave JC, Fesler P, Ribstein J, du Cailar G, Mimran A. Estimation of renal function in subjects with normal serum creatinine levels: Influence of age and body mass index. Am J Kidney Dis 2005;46:233-41.
10. Chertow GM, Burdick E, Honour M, Bonventre JV, Bates DW. Acute kidney injury, mortality, length of stay, and costs in hospitalized patients. J Am Soc Nephrol 2005;16:3365-70.
11. Levey AS, Coresh J. Chronic kidney disease. Lancet 2012;379:165-80.
12. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010;33 Suppl 1:S62-9. Erratum in: Diabetes Care 2010;33:e57.
13. Hunt SA, Abraham WT, Chin MH, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:e391-479. Erratum in Circulation. 2010;121:e258.
14. Ghani AA, Tohamy KY. Risk score for contrast induced nephropathy following percutaneous coronary intervention. Saudi J Kidney Dis Transpl 2009;20:240-5.
15. MacNeill BD, Harding SA, Bazari H, Patton KK, Colon-Hernadez P, DeJoseph D, et al. Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography. Catheter Cardiovasc Interv 2003;60:458-61.
16. th ed. Philadelphia, Saunders; 2007:2158-61.
17. Mager A, Vaknin Assa H, Lev EI, Bental T, Assali A, Kornowski R. The ratio of contrast volume to glomerular filtration rate predicts outcomes after percutaneous coronary intervention for ST-segment elevation acute myocardial infarction. Catheter Cardiovasc Interv 2011;78:198-201.
18. Worasuwannarak S, Pornratanarangsi S. Prediction of contrast-induced nephropathy in diabetic patients undergoing elective cardiac catheterization or PCI: Role of volume-to-creatinine clearance ratio and iodine dose-to-creatinine clearance ratio. J Med Assoc Thai 2010;93 Suppl 1:S29-34.
19. Rihal CS, Textor SC, Grill DE, Berger PB, Ting HH, Best PJ, et al. Incidence and prognostic importance of acute kidney injury after percutaneous coronary intervention. Circulation 2002;105:2259-64.
20. Barrett BJ, Parfrey PS, Vavasour HM, McDonald J, Kent G, Hefferton D, et al. Contrast nephropathy in patients with impaired renal function: High versus low osmolar media. Kidney Int 1992;41:1274-9.
21. Barrett BJ, Carlisle EJ. Metaanalysis of the relative nephrotoxicity of high-and low-osmolality iodinated contrast media. Radiology 1993;188:171-8.
22. Valente S, Lazzeri C, Giglioli C, Margheri M, Comeglio M, Nicolaci L, et al. Contrast-induced nephropathy in urgent coronary interventions. J Cardiovasc Med (Hagerstown) 2006;7:737-41.
23. Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: Evaluation, classification, and stratification. Ann Intern Med 2003;139:137-47.